Fexofenadine HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

81 API Suppliers, 24 USDMF, 12 CEP/COS, 15 JDMF, 13 EU WC, 9 KDMF, 25 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

26 API Suppliers

26 API Suppliers

FINISHED DOSAGE FORMULATIONS

285 FDF Dossiers, 96 FDA Orange Book, 76 Europe, 4 Canada, 5 Australia, 30 South Africa, 74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 30MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, TABLET;ORAL - 180MG, TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 11 DKSH, 3 Jai Radhe Sales, 2 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 55 Direct Compression, 44 Disintegrants & Superdisintegrants, 44 Thickeners and Stabilizers, 36 Controlled & Modified Release, 36 Granulation, 32 Solubilizers, 31 Taste Masking, 29 Lubricants & Glidants, 28 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Topical, 21 Parenteral, 21 Co-Processed Excipients, 9 Empty Capsules, 9 API Stability Enhancers, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

74 Finished Drug Prices, 9 Annual Reports

MARKET PLACE

32 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 13 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 JP, 6 Others

ANALYTICAL

1 BioAnalytical Methods, 5 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20872 / DOSAGE - TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
fexofenadine hydrochloride(UNII: 2S068B75ZU) (Fexofenadine - UNII:E6582LOH6V)	fexofenadine hydrochloride	180mg

Inactive Ingredients

Ingredient Name	sanofi-aventis U.S. LLC	Chattem, Inc.	Sanofi-Synthelabo Limited	NCS HealthCare of KY, Inc dba Vangard Labs	Navajo Manufacturing Company Inc.
anhydrous citric acid(XF417D3PSL)
aspartame(Z0H242BBR1)
BROWN IRON OXIDE(1N032N7MFO)
butylparaben(3QPI1U3FV8)
cellulose acetate(3J2P07GVB6)
cellulose, microcrystalline(OP1R32D61U)
CROSCARMELLOSE SODIUM(M28OL1HH48)
crospovidone(68401960MK)
D&C RED NO. 28(767IP0Y5NH)
D&C RED NO. 33(9DBA0SBB0L)
edetate disodium(7FLD91C86K)
FD&C BLUE NO. 1(H3R47K3TBD)
FERROUS OXIDE(G7036X8B5H)
GELATIN(2G86QN327L)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
hypromellose(3NXW29V3WO)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
mannitol(3OWL53L36A)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
poloxamer 407(TUF2IVW3M2)
POLYETHYLENE GLYCOL 6000(30IQX730WE)
polyethylene glycol(3WJQ0SDW1A)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
polyethylene glycols(3WJQ0SDW1A)
povidone K30(U725QWY32X)
POVIDONE(FZ989GH94E)
propylene glycol(6DC9Q167V3)
propylparaben(Z8IX2SC1OH)
SILICON DIOXIDE(ETJ7Z6XBU4)
sodium bicarbonate(8MDF5V39QO)
sodium chloride(451W47IQ8X)
sodium phosphate, dibasic, heptahydrate(70WT22SF4B)
sodium phosphate, monobasic, monohydrate(593YOG76RN)
STARCH, CORN(O8232NY3SJ)
sucrose(C151H8M554)
titanium dioxide(15FIX9V2JP)
water(059QF0KO0R)
xanthan gum(TTV12P4NEE)
xylitol(VCQ006KQ1E)

Drug Product Composition: Fexofenadine HCl